New Annex 1, among other important points considered, dedicates several comments on the importance and the impact of Critical Utilities, involved at different level either because directly impacting on Contamination Control Strategy (CCS) document, or because potential direct or indirect source of bio-contamination of the final product.
EU MDR 2017-745: New Cybersecurity Requirements for Networked MD producers by Danilo […]
New EU GMP Annex 1 – Implications for QRM application by Alessio […]
Covid-19 vaccines supply chain has become a target for cybersecurity attacks. How […]
A snapshot of Serialization in Pharmaceutical Industry. by Danilo Neri, PQE Group […]
Data Privacy and Personal Freedom: How are they influenced by technology in […]
How the Covid-19 crisis differs from the economic crises in the past?
European Medicines Regulatory Network agreed to proceed with the extension of the Step 1 (risk evaluation) deadline to October 1st, 2020, due to Covid-19 spreading.
Nitrosamine Risk Assessment (Step 1): new deadlines for BIO and Chemical products […]
How Government Policies affect the number of COVID 19 infections worldwide? – […]